Literature DB >> 21700829

Casual blood pressure and neurocognitive function in children with chronic kidney disease: a report of the children with chronic kidney disease cohort study.

Marc B Lande1, Arlene C Gerson, Stephen R Hooper, Christopher Cox, Matt Matheson, Susan R Mendley, Debbie S Gipson, Cynthia Wong, Bradley A Warady, Susan L Furth, Joseph T Flynn.   

Abstract

BACKGROUND AND OBJECTIVES: Children with chronic kidney disease (CKD) are at risk for cognitive dysfunction, and over half have hypertension. Data on the potential contribution of hypertension to CKD-associated neurocognitive deficits in children are limited. Our objective was to determine whether children with CKD and elevated BP (EBP) had decreased performance on neurocognitive testing compared with children with CKD and normal BP. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This was a cross-sectional analysis of the relation between auscultatory BP and neurocognitive test performance in children 6 to 17 years enrolled in the Chronic Kidney Disease in Children (CKiD) project.
RESULTS: Of 383 subjects, 132 (34%) had EBP (systolic BP and/or diastolic BP ≥90(th) percentile). Subjects with EBP had lower mean (SD) scores on Wechsler Abbreviated Scales of Intelligence (WASI) Performance IQ than those with normal BP (normal BP versus EBP, 96.1 (16.7) versus 92.4 (14.9), P = 0.03) and WASI Full Scale IQ (97.0 (16.2) versus 93.4 (16.5), P = 0.04). BP index (subject's BP/95(th) percentile BP) correlated inversely with Performance IQ score (systolic, r = -0.13, P = 0.01; diastolic, r = -0.19, P < 0.001). On multivariate analysis, the association between lower Performance IQ score and increased BP remained significant after controlling for demographic and disease-related variables (EBP, β = -3.7, 95% confidence interval [CI]: -7.3 to -0.06; systolic BP index, β = -1.16 to 95% CI: -2.1, -0.21; diastolic BP index, β = -1.17, 95% CI: -1.8 to -0.55).
CONCLUSIONS: Higher BP was independently associated with decreased WASI Performance IQ scores in children with mild-to-moderate CKD.

Entities:  

Mesh:

Year:  2011        PMID: 21700829      PMCID: PMC3156422          DOI: 10.2215/CJN.00810111

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  17 in total

1.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

Review 2.  "Object vision" and "spatial vision": the neuropsychological evidence for the distinction.

Authors:  G Ettlinger
Journal:  Cortex       Date:  1990-09       Impact factor: 4.027

Review 3.  Neurocognitive outcomes in children with chronic kidney disease: Current findings and contemporary endeavors.

Authors:  Arlene C Gerson; Robert Butler; Marva Moxey-Mims; Alicia Wentz; Shlomo Shinnar; Marc B Lande; Susan R Mendley; Bradley A Warady; Susan L Furth; Stephen R Hooper
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2006

4.  Parental assessment of executive function and internalizing and externalizing behavior in primary hypertension after anti-hypertensive therapy.

Authors:  Marc B Lande; Heather Adams; Bonita Falkner; Shari R Waldstein; George J Schwartz; Peter G Szilagyi; Hongyue Wang; Donna Palumbo
Journal:  J Pediatr       Date:  2010-03-15       Impact factor: 4.406

5.  Memory and executive functions in pediatric chronic kidney disease.

Authors:  Debbie S Gipson; Stephen R Hooper; Peter J Duquette; Crista E Wetherington; Kurt K Stellwagen; Tonya L Jenkins; Maria E Ferris
Journal:  Child Neuropsychol       Date:  2006-12       Impact factor: 2.500

6.  Glomerular filtration rate via plasma iohexol disappearance: pilot study for chronic kidney disease in children.

Authors:  G J Schwartz; S Furth; S R Cole; B Warady; A Muñoz
Journal:  Kidney Int       Date:  2006-06       Impact factor: 10.612

7.  Hypertension and progression of chronic renal insufficiency in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).

Authors:  Mark Mitsnefes; Ping-Leung Ho; Paul T McEnery
Journal:  J Am Soc Nephrol       Date:  2003-10       Impact factor: 10.121

8.  Effects of six anti-hypertensive medications on cognitive performance.

Authors:  Matthew F Muldoon; Shari R Waldstein; Christopher M Ryan; John Richard Jennings; Joanna M Polefrone; Alvin P Shapiro; Stephen B Manuck
Journal:  J Hypertens       Date:  2002-08       Impact factor: 4.844

9.  Elevated blood pressure and decreased cognitive function among school-age children and adolescents in the United States.

Authors:  Marc B Lande; Jeffrey M Kaczorowski; Peggy Auinger; George J Schwartz; Michael Weitzman
Journal:  J Pediatr       Date:  2003-12       Impact factor: 4.406

Review 10.  Neuropsychological consequences of antihypertensive medication use.

Authors:  M F Muldoon; S R Waldstein; J R Jennings
Journal:  Exp Aging Res       Date:  1995 Oct-Dec       Impact factor: 1.645

View more
  29 in total

1.  Mental health and psychosocial adjustment in pediatric chronic kidney disease derived from the KNOW-Ped CKD study.

Authors:  Na Ri Kang; Yo Han Ahn; Eujin Park; Hyun Jin Choi; Seong Heon Kim; Heeyeon Cho; Min Hyun Cho; Jae Il Shin; Joo Hoon Lee; Young Seo Park; Hae Il Cheong; Hee Gyung Kang; Il-Soo Ha; Young Sook Kwack; Kyoung Hee Han
Journal:  Pediatr Nephrol       Date:  2019-06-20       Impact factor: 3.714

2.  A predictive model of progression of CKD to ESRD in a predialysis pediatric interdisciplinary program.

Authors:  Debora C Cerqueira; Cristina M Soares; Vanessa R Silva; Juliana O Magalhães; Isabella P Barcelos; Mariana G Duarte; Sergio V Pinheiro; Enrico A Colosimo; Ana Cristina Simões e Silva; Eduardo A Oliveira
Journal:  Clin J Am Soc Nephrol       Date:  2014-01-23       Impact factor: 8.237

Review 3.  CKiD (CKD in children) prospective cohort study: a review of current findings.

Authors:  Cynthia J Wong; Marva Moxey-Mims; Judith Jerry-Fluker; Bradley A Warady; Susan L Furth
Journal:  Am J Kidney Dis       Date:  2012-09-28       Impact factor: 8.860

Review 4.  Autosomal recessive polycystic kidney disease: a hepatorenal fibrocystic disorder with pleiotropic effects.

Authors:  Erum A Hartung; Lisa M Guay-Woodford
Journal:  Pediatrics       Date:  2014-08-11       Impact factor: 7.124

Review 5.  Cognitive function in hypertensive children.

Authors:  Marc B Lande; Juan C Kupferman
Journal:  Curr Hypertens Rep       Date:  2015-01       Impact factor: 5.369

Review 6.  Treatment of hypertension in children with chronic kidney disease.

Authors:  Susan Halbach; Joseph Flynn
Journal:  Curr Hypertens Rep       Date:  2015-01       Impact factor: 5.369

7.  Environmental lead exposure is associated with neurocognitive dysfunction in children with chronic kidney disease.

Authors:  Rebecca L Ruebner; Stephen R Hooper; Carisa Parrish; Susan L Furth; Jeffrey J Fadrowski
Journal:  Pediatr Nephrol       Date:  2019-07-20       Impact factor: 3.714

Review 8.  Blood pressure in children with chronic kidney disease: lessons learned from the Chronic Kidney Disease in Children Cohort Study.

Authors:  Amy C Wilson; Joseph T Flynn
Journal:  Pediatr Nephrol       Date:  2019-08-08       Impact factor: 3.714

9.  Recognition and Management of Elevated Blood Pressure in Pediatric Patients: Challenges and Disparities in Community Health Centers.

Authors:  Rikki L Ward; Jessica M Robbins; Rebecca N Haden; Brittany J Benson; Issy C Esangbedo
Journal:  J Community Health       Date:  2016-04

Review 10.  Blood Pressure and Cognitive Function in Children and Adolescents.

Authors:  Marc B Lande; Juan C Kupferman
Journal:  Hypertension       Date:  2019-03       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.